SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-032858
Filing Date
2019-08-23
Accepted
2019-08-23 07:20:57
Documents
3
Period of Report
2019-10-02
Effectiveness Date
2019-08-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A kalv-def14a_20191002.htm DEF 14A 660613
2 GRAPHIC gkkn2gnx5hps000001.jpg GRAPHIC 76572
3 GRAPHIC gkkn2gnx5hps000002.jpg GRAPHIC 51675
  Complete submission text file 0001564590-19-032858.txt   838875
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-36830 | Film No.: 191047099
SIC: 2834 Pharmaceutical Preparations